Skip to main content
Top
Published in: Internal and Emergency Medicine 4/2020

01-06-2020 | Obesity | IM - REVIEW

Cardio-metabolic problem in Egypt

Authors: Mona Amin, Amal Radwan, Afaf Hemeda

Published in: Internal and Emergency Medicine | Issue 4/2020

Login to get access

Abstract

Thirty years ago, chronic conditions such as diabetes, heart disease, and obesity accounted for less than 45% of the global disease burden. Today, they are the leading causes of death and disability worldwide, having surpassed infectious diseases such as HIV/AIDS and malaria. We have understood for decades the roles of ‘classical’ risk factors including elevated LDL-cholesterol, hypertension, elevated blood glucose, and smoking in the pathogenesis of cardiovascular disease. More recent research is continuing to define the contribution of other emerging factors to the risk of developing cardiovascular disease, particularly abdominal obesity that is associated with atherogenic dyslipidemia, insulin resistance, chronic inflammation, and prothrombotic state. All these factors constitute the global cardiometabolic risk that plays a significant role in development of cardiovascular disease.
Literature
1.
go back to reference Srivastava AK (2012) Challenges in the treatment of cardiometabolic syndrome. Indian J Pharmacol 44(2):155–156CrossRef Srivastava AK (2012) Challenges in the treatment of cardiometabolic syndrome. Indian J Pharmacol 44(2):155–156CrossRef
2.
go back to reference Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32:14–23CrossRef Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32:14–23CrossRef
3.
go back to reference Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metabol 89(6):2548–2556CrossRef Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metabol 89(6):2548–2556CrossRef
5.
go back to reference Seattle WA (2010) Global burden of diseases, injuries, and risk factors study. Institute for Health Metrics and Evaluation Seattle WA (2010) Global burden of diseases, injuries, and risk factors study. Institute for Health Metrics and Evaluation
6.
go back to reference Ibrahim MM (2014) The egyptian hypertension society, Egyptian hypertension guidelines. The Egyptian society of cardiology. Egypt Heart J 66:79–132 Ibrahim MM (2014) The egyptian hypertension society, Egyptian hypertension guidelines. The Egyptian society of cardiology. Egypt Heart J 66:79–132
9.
go back to reference Cho NH, Shawb JE, Karurangaa S, Huanga Y et al (2011) IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271–281CrossRef Cho NH, Shawb JE, Karurangaa S, Huanga Y et al (2011) IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271–281CrossRef
10.
go back to reference Mowafi M, Khadr Z, Kawachi I et al (2014) Socioeconomic status and obesity in Cairo, Egypt: a heavy burden for all. J Epidemiol Global Health 4:13–21CrossRef Mowafi M, Khadr Z, Kawachi I et al (2014) Socioeconomic status and obesity in Cairo, Egypt: a heavy burden for all. J Epidemiol Global Health 4:13–21CrossRef
11.
go back to reference World health Organization (WHO) Report (2017) World health Organization (WHO) Report (2017)
12.
go back to reference Farrag A, El Eraky A, El Aroussy W et al (2015) Obesity and other cardiovascular risk factors in Egyptian University Students: magnitude of the problem. Epidemiology 5(1):1000181 Farrag A, El Eraky A, El Aroussy W et al (2015) Obesity and other cardiovascular risk factors in Egyptian University Students: magnitude of the problem. Epidemiology 5(1):1000181
13.
go back to reference Ellabany E, Nasser AM (2005–2006) WHO Eastern Mediterranean Regional Office. In: Collaboration with USAID. Cairo Ellabany E, Nasser AM (2005–2006) WHO Eastern Mediterranean Regional Office. In: Collaboration with USAID. Cairo
15.
go back to reference Abelaziz A, Fawzy M (2014) Prevalence and pattern of dyslipidemia in ACS patients admitted to medical ICU. In: Zagazig University Hospital. Internal Medicine and Biochemical departments Zagazig University. Z.U.M.J, 20 (3) Abelaziz A, Fawzy M (2014) Prevalence and pattern of dyslipidemia in ACS patients admitted to medical ICU. In: Zagazig University Hospital. Internal Medicine and Biochemical departments Zagazig University. Z.U.M.J, 20 (3)
16.
go back to reference Waked I, Esmat G, Elsharkawy A et al (2020) Screening and treatment program to eliminate hepatitis C in Egypt. NEJM 382:12CrossRef Waked I, Esmat G, Elsharkawy A et al (2020) Screening and treatment program to eliminate hepatitis C in Egypt. NEJM 382:12CrossRef
17.
go back to reference Haseltine WA (2020) Universal disease screening and treatment—the Egyptian example. NEJM 382:1CrossRef Haseltine WA (2020) Universal disease screening and treatment—the Egyptian example. NEJM 382:1CrossRef
Metadata
Title
Cardio-metabolic problem in Egypt
Authors
Mona Amin
Amal Radwan
Afaf Hemeda
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 4/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-020-02346-8

Other articles of this Issue 4/2020

Internal and Emergency Medicine 4/2020 Go to the issue